EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders

Laura Ivete Rudaks iD, Igor Stevanovski iD, Dennis Yeow, Andre L M Reis, Sanjog R Chintalaphani, Pak Leng Cheong, Hasindu Gamaarachchi, Lisa Worgan, Kate Ahmad, Michael Hayes, Andrew Hannaford, Samuel Kim und 9 weitere

Annals of Clinical and Translational Neurology · 2025-04 · 12 (4) · 832-841

DOI: 10.1002/acn3.70008 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Clinical and Translational Neurology, online erschienen am 25.02.2025. Verfasst von Laura Ivete Rudaks und 20 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, Concord, New South Wales, Australia. Hauptthemen laut MEDLINE: Spinocerebellar Ataxias, Muscle Spasticity, Genetic Testing, Optic Atrophy. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Future Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The hereditary spastic‐ataxia spectrum disorders are a group of disabling neurological diseases. The traditional genetic testing pathway is complex, multistep and leaves many cases unsolved. We aim to streamline and improve this process using long‐read sequencing.

Methods

We developed a targeted long‐read sequencing strategy with the capacity to characterise the genetic variation of all types and sizes within 469 disease‐associated genes, in a single assay. We applied this to a cohort of 34 individuals with unsolved spastic‐ataxia. An additional five individuals with a known genetic diagnosis were included as positive controls.

Results

We identified causative pathogenic variants that would be sufficient for genetic diagnosis in 14/34 (41%) unsolved participants. The success rate was 5/11 (45%) in those who were naïve to genetic testing and 9/23 (39%) in those who were undiagnosed after prior genetic testing, completed on a clinical basis. Short tandem repeat expansions in FGF14 were the most common (7/34, 21%). Two individuals (2/34, 6%) had biallelic pathogenic expansions in RFC1 and one individual had a monoallelic pathogenic expansion in ATXN8OS / ATXN8 . Causative pathogenic sequence variants other than short tandem repeat expansions were found in four individuals, including in VCP , STUB1 , ANO10 and SPG7 . Furthermore, all five positive controls were identified.

Interpretation

Our results demonstrate the utility of targeted long‐read sequencing in the genetic evaluation of patients with spastic‐ataxia spectrum disorders, highlighting both the capacity to increase overall diagnostic yield and to streamline the testing pathway by capturing all known genetic causes in a single assay.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Spinocerebellar AtaxiasMuscle SpasticityGenetic TestingOptic AtrophyHumansMaleFemaleAdultMiddle AgedAdolescentYoung AdultChildIntellectual Disability

Stichwörter der Autor:innen

hereditary cerebellar ataxiahereditary spastic paraplegiananopore sequencingspinocerebellar ataxia

Autor:innen und Institutionen

  • Molecular Medicine Laboratory and Neurology Department, Concord Repatriation General Hospital, Concord, New South Wales, Australia.
  • Faculty of Medicine and Health, University of Sydney, Camperdown, New South Wales, Australia.
  • Genomic and Inherited Disease Program, The Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Clinical Genetics Unit, Royal North Shore Hospital, St Leonards, New South Wales, Australia.
  • Centre for Population Genomics, The Garvan Institute of Medical Research, Darlinghurst, New South Wales, Australia.
  • Neurodegenerative Service, Prince of Wales Hospital, Randwick, New South Wales, Australia.

ORCID-Profile: Laura Ivete Rudaks, Igor Stevanovski, Kishore Raj Kumar

Förderung

  • Medical Research Future Fund

Zitieren

APA

Rudaks, L. I., Stevanovski, I., Yeow, D., Reis, A. L. M., Chintalaphani, S. R., Cheong, P. L., Gamaarachchi, H., Worgan, L., Ahmad, K., Hayes, M., Hannaford, A., Kim, S., Fung, V. S. C., Halmagyi, G. M., Martin, A., Manser, D., Tchan, M., Ng, K., Kennerson, M. L., …, & Kumar, K. R. (2025). Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders. Annals of Clinical and Translational Neurology, 12(4), 832-841. https://doi.org/10.1002/acn3.70008

Vancouver

Rudaks LI, Stevanovski I, Yeow D, Reis ALM, Chintalaphani SR, Cheong PL, et al. Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders. Annals of Clinical and Translational Neurology. 2025;12(4):832-841. doi:10.1002/acn3.70008

BibTeX
@article{Rudaks2025,
  author = {Rudaks, Laura Ivete and Stevanovski, Igor and Yeow, Dennis and Reis, Andre L M and Chintalaphani, Sanjog R and Cheong, Pak Leng and Gamaarachchi, Hasindu and Worgan, Lisa and Ahmad, Kate and Hayes, Michael and Hannaford, Andrew and Kim, Samuel and Fung, Victor S C and Halmagyi, Gabor M and Martin, Andrew and Manser, David and Tchan, Michel and Ng, Karl and Kennerson, Marina L and Deveson, Ira W and Kumar, Kishore Raj},
  title = {Targeted Long‐Read Sequencing as a Single Assay Improves the Diagnosis of Spastic‐Ataxia Disorders},
  journal = {Annals of Clinical and Translational Neurology},
  year = {2025},
  volume = {12},
  number = {4},
  pages = {832--841},
  doi = {10.1002/acn3.70008}
}
Kostenlos starten →